It's now sitting on a FY16 PE of 26.5 and FY17 PE of say 18, even with downgraded consensus numbers for revenue and EPS.
I believe BAL can navigate its way though some of the issues noted by Citi and continue to grow. I’m keeping the faith, but not immune from feeling some pain with the recent price action.
- Forums
- ASX - By Stock
- BAL
- There has been no statement from BAL
There has been no statement from BAL, page-3
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online